Daniel is a co-founder and CEO at InVivo AI, a venture-backed startup developing novel algorithms for use in drug discovery. Previously, he worked as a member of the investment team at Lumira Ventures, a healthcare investment fund, and was part of the founding team at Front Row Ventures, Canada's first student-led venture capital fund.

Daniel holds a dual degree in honors neuroscience and computer science and a master's degree in computational neuroscience from McGill University.